Brief: GeneDx Regains Compliance With Nasdaq Minimum Bid Price Requirement
22/05/2023 22:48
May 22 (Reuters) - GeneDx Holdings Corp WGS.O :
* GENEDX REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE
REQUIREMENT
Source text for Eikon: ID:nGNX8hmVfN
Further company coverage: WGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth